 | • レポートコード：MRC309Z7796 • 出版社/出版日：GlobalInfoResearch / 2023年9月20日 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のウシヘパリンナトリウムの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のウシヘパリンナトリウム市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - ウシヘパリンナトリウムの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため ウシヘパリンナトリウム市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・タイプA、タイプB 用途別セグメント ・静脈血栓塞栓症治療、心房細動&粗動における電気的除細動、妊娠合併症、その他 主要な市場プレーヤー ・Kin Master Produtos Químicos Ltda、Syntex、Bacto Chem、Wegmed - Caminhos Medicinais Ltda、Alliance Brasil、Ralington Pharma、Hebei Changshan Biochemical Pharmaceutical、Suzhou Ronnsi Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ウシヘパリンナトリウム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なウシヘパリンナトリウムメーカーの企業概要、2019年～2022年までのウシヘパリンナトリウムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なウシヘパリンナトリウムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別ウシヘパリンナトリウムの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのウシヘパリンナトリウムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのウシヘパリンナトリウム市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびウシヘパリンナトリウムの産業チェーンを掲載しています。 ・第14、15章では、ウシヘパリンナトリウムの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - ウシヘパリンナトリウムの概要 - 種類別分析（2018年vs2022年vs2029年）：タイプA、タイプB - 用途別分析（2018年vs2022年vs2029年）：静脈血栓塞栓症治療、心房細動&粗動における電気的除細動、妊娠合併症、その他 - 世界のウシヘパリンナトリウム市場規模・予測 - 世界のウシヘパリンナトリウム生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Kin Master Produtos Químicos Ltda、Syntex、Bacto Chem、Wegmed - Caminhos Medicinais Ltda、Alliance Brasil、Ralington Pharma、Hebei Changshan Biochemical Pharmaceutical、Suzhou Ronnsi Pharma ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：タイプA、タイプB ・用途別分析2018年-2029年：静脈血栓塞栓症治療、心房細動&粗動における電気的除細動、妊娠合併症、その他 ・ウシヘパリンナトリウムの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ウシヘパリンナトリウムのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ウシヘパリンナトリウムのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ウシヘパリンナトリウムの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ウシヘパリンナトリウムの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Bovine Heparin Sodium market size was valued at USD 41 million in 2022 and is forecast to a readjusted size of USD 60 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global 5 largest manufacturers of Bovine Heparin Sodium are Bacto Chem, Syntex, Kin Master Produtos Químicos Ltda, Alliance Brasil and Ralington Pharma, which make up over 70%. Among them, Bacto Chem dominates with over 20% production value share, followed by Syntex (17%) and Kin Master Produtos Químicos Ltda (14%). Top manufacturers are based in South America, India and China.
Asia Pacific is the largest market, holding a share over 30%, followed by Europe and South America, with shares 30% and 20% separately.
Based on the product type, the Bovine Heparin Sodium is split into Type A and Type B.
Based on the product Application, the Bovine Heparin Sodium is primarily split into Treatment of Venous Thromboembolism, Cardioversion of Atrial Fibrillation/Flutter and Complications of Pregnancy. The largest segment is Treatment of Venous Thromboembolism, accounting for nearly 70%.
Bovine intestinal enoxaparin sodium and its injections can be used in anticoagulant, antithrombotic, anti-inflammatory, anticancer and halal drugs, that is, it has the halal property that porcine enoxaparin sodium does not have, and is widely used in Muslims, countries and countries. The region has a huge market.
This report is a detailed and comprehensive analysis for global Bovine Heparin Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bovine Heparin Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Bovine Heparin Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Bovine Heparin Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Bovine Heparin Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bovine Heparin Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bovine Heparin Sodium market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kin Master Produtos Químicos Ltda, Syntex, Bacto Chem, Wegmed – Caminhos Medicinais Ltda and Alliance Brasil, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Bovine Heparin Sodium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Type A
Type B
Market segment by Application
Treatment of Venous Thromboembolism
Cardioversion of Atrial Fibrillation/Flutter
Complications of Pregnancy
Others
Major players covered
Kin Master Produtos Químicos Ltda
Syntex
Bacto Chem
Wegmed – Caminhos Medicinais Ltda
Alliance Brasil
Ralington Pharma
Hebei Changshan Biochemical Pharmaceutical
Suzhou Ronnsi Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bovine Heparin Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bovine Heparin Sodium, with price, sales, revenue and global market share of Bovine Heparin Sodium from 2018 to 2023.
Chapter 3, the Bovine Heparin Sodium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bovine Heparin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bovine Heparin Sodium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bovine Heparin Sodium.
Chapter 14 and 15, to describe Bovine Heparin Sodium sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Bovine Heparin Sodium
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bovine Heparin Sodium Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Type A
1.3.3 Type B
1.4 Market Analysis by Application
1.4.1 Overview: Global Bovine Heparin Sodium Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Treatment of Venous Thromboembolism
1.4.3 Cardioversion of Atrial Fibrillation/Flutter
1.4.4 Complications of Pregnancy
1.4.5 Others
1.5 Global Bovine Heparin Sodium Market Size & Forecast
1.5.1 Global Bovine Heparin Sodium Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Bovine Heparin Sodium Sales Quantity (2018-2029)
1.5.3 Global Bovine Heparin Sodium Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Kin Master Produtos Químicos Ltda
2.1.1 Kin Master Produtos Químicos Ltda Details
2.1.2 Kin Master Produtos Químicos Ltda Major Business
2.1.3 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Product and Services
2.1.4 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Kin Master Produtos Químicos Ltda Recent Developments/Updates
2.2 Syntex
2.2.1 Syntex Details
2.2.2 Syntex Major Business
2.2.3 Syntex Bovine Heparin Sodium Product and Services
2.2.4 Syntex Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Syntex Recent Developments/Updates
2.3 Bacto Chem
2.3.1 Bacto Chem Details
2.3.2 Bacto Chem Major Business
2.3.3 Bacto Chem Bovine Heparin Sodium Product and Services
2.3.4 Bacto Chem Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bacto Chem Recent Developments/Updates
2.4 Wegmed – Caminhos Medicinais Ltda
2.4.1 Wegmed – Caminhos Medicinais Ltda Details
2.4.2 Wegmed – Caminhos Medicinais Ltda Major Business
2.4.3 Wegmed – Caminhos Medicinais Ltda Bovine Heparin Sodium Product and Services
2.4.4 Wegmed – Caminhos Medicinais Ltda Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wegmed – Caminhos Medicinais Ltda Recent Developments/Updates
2.5 Alliance Brasil
2.5.1 Alliance Brasil Details
2.5.2 Alliance Brasil Major Business
2.5.3 Alliance Brasil Bovine Heparin Sodium Product and Services
2.5.4 Alliance Brasil Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alliance Brasil Recent Developments/Updates
2.6 Ralington Pharma
2.6.1 Ralington Pharma Details
2.6.2 Ralington Pharma Major Business
2.6.3 Ralington Pharma Bovine Heparin Sodium Product and Services
2.6.4 Ralington Pharma Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ralington Pharma Recent Developments/Updates
2.7 Hebei Changshan Biochemical Pharmaceutical
2.7.1 Hebei Changshan Biochemical Pharmaceutical Details
2.7.2 Hebei Changshan Biochemical Pharmaceutical Major Business
2.7.3 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Product and Services
2.7.4 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
2.8 Suzhou Ronnsi Pharma
2.8.1 Suzhou Ronnsi Pharma Details
2.8.2 Suzhou Ronnsi Pharma Major Business
2.8.3 Suzhou Ronnsi Pharma Bovine Heparin Sodium Product and Services
2.8.4 Suzhou Ronnsi Pharma Bovine Heparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Suzhou Ronnsi Pharma Recent Developments/Updates
3 Competitive Environment: Bovine Heparin Sodium by Manufacturer
3.1 Global Bovine Heparin Sodium Sales Quantity by Manufacturer (2018-2023)
3.2 Global Bovine Heparin Sodium Revenue by Manufacturer (2018-2023)
3.3 Global Bovine Heparin Sodium Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Bovine Heparin Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Bovine Heparin Sodium Manufacturer Market Share in 2022
3.4.2 Top 6 Bovine Heparin Sodium Manufacturer Market Share in 2022
3.5 Bovine Heparin Sodium Market: Overall Company Footprint Analysis
3.5.1 Bovine Heparin Sodium Market: Region Footprint
3.5.2 Bovine Heparin Sodium Market: Company Product Type Footprint
3.5.3 Bovine Heparin Sodium Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Bovine Heparin Sodium Market Size by Region
4.1.1 Global Bovine Heparin Sodium Sales Quantity by Region (2018-2029)
4.1.2 Global Bovine Heparin Sodium Consumption Value by Region (2018-2029)
4.1.3 Global Bovine Heparin Sodium Average Price by Region (2018-2029)
4.2 North America Bovine Heparin Sodium Consumption Value (2018-2029)
4.3 Europe Bovine Heparin Sodium Consumption Value (2018-2029)
4.4 Asia-Pacific Bovine Heparin Sodium Consumption Value (2018-2029)
4.5 South America Bovine Heparin Sodium Consumption Value (2018-2029)
4.6 Middle East and Africa Bovine Heparin Sodium Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Bovine Heparin Sodium Sales Quantity by Type (2018-2029)
5.2 Global Bovine Heparin Sodium Consumption Value by Type (2018-2029)
5.3 Global Bovine Heparin Sodium Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Bovine Heparin Sodium Sales Quantity by Application (2018-2029)
6.2 Global Bovine Heparin Sodium Consumption Value by Application (2018-2029)
6.3 Global Bovine Heparin Sodium Average Price by Application (2018-2029)
7 North America
7.1 North America Bovine Heparin Sodium Sales Quantity by Type (2018-2029)
7.2 North America Bovine Heparin Sodium Sales Quantity by Application (2018-2029)
7.3 North America Bovine Heparin Sodium Market Size by Country
7.3.1 North America Bovine Heparin Sodium Sales Quantity by Country (2018-2029)
7.3.2 North America Bovine Heparin Sodium Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Bovine Heparin Sodium Sales Quantity by Type (2018-2029)
8.2 Europe Bovine Heparin Sodium Sales Quantity by Application (2018-2029)
8.3 Europe Bovine Heparin Sodium Market Size by Country
8.3.1 Europe Bovine Heparin Sodium Sales Quantity by Country (2018-2029)
8.3.2 Europe Bovine Heparin Sodium Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Bovine Heparin Sodium Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Bovine Heparin Sodium Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Bovine Heparin Sodium Market Size by Region
9.3.1 Asia-Pacific Bovine Heparin Sodium Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Bovine Heparin Sodium Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Bovine Heparin Sodium Sales Quantity by Type (2018-2029)
10.2 South America Bovine Heparin Sodium Sales Quantity by Application (2018-2029)
10.3 South America Bovine Heparin Sodium Market Size by Country
10.3.1 South America Bovine Heparin Sodium Sales Quantity by Country (2018-2029)
10.3.2 South America Bovine Heparin Sodium Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Bovine Heparin Sodium Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Bovine Heparin Sodium Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Bovine Heparin Sodium Market Size by Country
11.3.1 Middle East & Africa Bovine Heparin Sodium Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Bovine Heparin Sodium Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Bovine Heparin Sodium Market Drivers
12.2 Bovine Heparin Sodium Market Restraints
12.3 Bovine Heparin Sodium Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Bovine Heparin Sodium and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bovine Heparin Sodium
13.3 Bovine Heparin Sodium Production Process
13.4 Bovine Heparin Sodium Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bovine Heparin Sodium Typical Distributors
14.3 Bovine Heparin Sodium Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
